REVELATION BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.18 USD | +1.87% |
|
-2.68% | -85.49% |
Chart calendar Revelation Biosciences, Inc.
8d456d493cdcc40388dce503319.Oshtm1KESPjgAzD0vaQ1Sv_3p0J_kgl-TsXchri9l_Q.bKkVrBqpBY6UMUq289B2JMe2xjIm1jEkG6aDvsHI445YrQXSF9dwlZVOXw~e0b34add31ee6ad97d8a19c21a294662
Upcoming events on Revelation Biosciences, Inc.
Past events on Revelation Biosciences, Inc.
| 2024-03-22 04:15 pm | Q4 2023 Earnings Release |
| 2024-03-18 02:00 pm | Roth Conference |
| 2024-03-16 | Roth Conference |
| 2024-03-12 08:30 pm | Critical Care Nephrology International Conference |
| 2024-01-17 12:00 pm | Extraordinary Shareholders Meeting |
| 2023-11-13 04:05 pm | Q3 2023 Earnings Release |
| 2023-10-12 08:45 am | Roth Healtcare Opportunities Conference |
| 2023-08-11 04:10 pm | Q2 2023 Earnings Release |
| 2023-07-07 01:00 pm | Annual General Meeting |
| 2023-03-30 05:42 pm | Q4 2022 Earnings Release |
| 2023-03-14 03:30 pm | Roth Conference |
| 2023-01-19 | Extraordinary Shareholders Meeting |
| 2022-11-10 04:30 pm | Q3 2022 Earnings Release |
| 2022-10-05 | Roth Healthcare Opportunities Conference |
| 2022-08-15 05:30 pm | Interim 2022 Earnings Release |
| 2022-05-16 04:01 pm | Q1 2022 Earnings Release |
| 2022-04-07 04:30 pm | Business Update Call |
| 2022-03-27 | Maxim Group Virtual Growth Conference |
| 2022-03-15 11:00 am | Roth Capital Partners Conference |
| 2022-02-14 10:45 am | Bio CEO & Investor Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -3,09 -11,7 73.65% | -10,9 -10,9 -0.05% | -8,66 -9,29 6.77% | -10,4 |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
Net income Million USD | Released Forecast Spread | -5,08 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EPS USD | Released Forecast Spread | -4 599 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
| Announcement Date | 20/09/21 | 15/04/22 | 30/03/23 | 22/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -6,59 -2,00 -228.66% | -1,86 -2,12 12.29% | -1,20 -1,89 36.47% | -1,22 -1,21 -0.52% | -1,62 -1,64 0.99% | -1,93 -1,72 -12.64% | -2,78 -2,11 -31.46% | -2,33 -2,95 21.26% | -2,55 | -2,69 | -2,84 | -3,01 | |
| Announcement Date | 16/05/22 | 15/08/22 | 10/11/22 | 30/03/23 | 22/05/23 | 11/08/23 | 09/11/23 | 22/03/24 | - | - | - | - | - |
More events
Past sector events for Revelation Biosciences, Inc.
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 07:00 am | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 2024-04-25 02:00 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
- Stock Market
- Equities
- REVB Stock
- Calendar Revelation Biosciences, Inc.
